title: The use of combined chemotherapy for the treatment of advanced sarcoma of the uterus.
authors.affiliation: 4th Dept. of Obstetrics and Gynecology, Aristotelian University of Thessaloniki, Hippocration General Hospital, Greece.
authors.forename: G
authors.initials: G
authors.lastname: Psikakos
authors.forename: A
authors.initials: A
authors.lastname: Papanicolaou
authors.forename: L
authors.initials: L
authors.lastname: Boutis
authors.forename: M
authors.initials: M
authors.lastname: Goutzioulis
authors.forename: G
authors.initials: G
authors.lastname: Makedos
authors.forename: N
authors.initials: N
authors.lastname: Papanicolaou
mesh_terms: D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002945:Cisplatin / Q000008:administration & dosage; D003131:Combined Modality Therapy; D003520:Cyclophosphamide / Q000008:administration & dosage; D003606:Dacarbazine / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D005260:Female; D006801:Humans; D007069:Ifosfamide / Q000008:administration & dosage; D008875:Middle Aged; D012189:Retrospective Studies; D012509:Sarcoma / Q000188:drug therapy* / Q000556:secondary / Q000628:therapy; D015996:Survival Rate; D014594:Uterine Neoplasms / Q000188:drug therapy* / Q000473:pathology / Q000628:therapy; D014750:Vincristine / Q000008:administration & dosage
chemical_list: D014750:Vincristine; D003606:Dacarbazine; D004317:Doxorubicin; D003520:Cyclophosphamide; D002945:Cisplatin; D007069:Ifosfamide